CHENGDA PHARMA
30120127.742.44% ( +0.66 )
CHENGDA PHARMA (301201)
ChengDa Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates, active pharmaceutical ingredien...
- Open
- 27.57
- High
- 28.67
- Low
- 27.56
- Prev. Close
- 27.08
- Volume
- 66.98K
- Turnover
- 188.28M
- Avg Price
- 28.11
- Bid/Ask Ratio
- --
- Amplitude
- 4.10%
- 52wk High
- 64.83
- Volume Ratio
- 0.63
- Turnover Ratio
- 4.33%
News
- PUBT · 19 hours ago
CEC Capital advises Zhongkexinyang on 100-million-yuan private financing round
- Wallstreetcn · Apr 8 at 10:30 PM
Midday Market Review on April 9: SSE Index Drops 0.73% in Half-Day, Computing Power Hardware Stocks Strengthen Against the Trend
- 36Kr · Nov 12, 2025 at 05:31 AM
CHENGDA PHARMA: Elected Ge Jianli as Chairman
- Zhitong · Oct 27, 2025 at 06:32 AM
CHENGDA PHARMA released its performance for the first three quarters, with a net profit attributable to the parent company of 16.7733 million yuan, a decrease of 58.47%
- Zhitong · Sep 5, 2025 at 06:34 AM
CHENGDA PHARMA: Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership) plans to reduce its holdings by no more than 7.27%
- Zhitong · Aug 26, 2025 at 09:01 PM
Shibeikang announced the completion of Series B financing, with listed company CHENGDA PHARMA as the exclusive strategic investor
